A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

This study has suspended participant recruitment.
(Study suspended prior to enrollment)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )
ClinicalTrials.gov Identifier:
NCT01604863
First received: January 23, 2012
Last updated: October 29, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)